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A B S T R A C T
Traffic-related air pollution (TRAP) is a complex mixture of compounds that contributes to the pathogenesis of
many diseases including several types of cancer, pulmonary, cardiovascular and neurodegenerative diseases, and
more recently also diabetes mellitus. In search of an early diagnostic biomarker for improved environmental
health risk assessment, recent human studies have shown that certain extracellular miRNAs are altered upon
exposure to TRAP. Here, we present a global circulating miRNA analysis in a human population exposed to
different levels of TRAP. The cross-over study, with sampling taking place during resting and physical activity in
two different exposure scenarios, included for each subject personal exposure measurements of PM10,PM2.5, NO,
NO2, CO, CO2, BC and UFP. Next-generation sequencing technology was used to identify global circulating
miRNA levels across all subjects. We identified 8 miRNAs to be associated with the mixture of TRAP and 27
miRNAs that were associated with the individual pollutants NO, NO2, CO, CO2, BC and UFP. We did not find
significant associations between miRNA levels and PM10 or PM2.5. Integrated network analysis revealed that
these circulating miRNAs are potentially involved in processes that are implicated in the development of air
pollution-induced diseases. Altogether, this study demonstrates that signatures consisting of circulating miRNAs
present a potential novel biomarker to be used in health risk assessment.
1. Introduction
The WHO estimated that worldwide>80% of the people in cities
are exposed to air pollution levels that exceed the air quality limits
(WHO, 2017). A major source of urban air pollution is motor vehicle
emissions. These traffic-related air pollutants (TRAP) constitute a
complex mixture of compounds including black carbon (BC), particu-
late matter (PM2.5, PM10), ultra-fine particles (UFP), nitrogen oxides
(NO, NOx) and carbon oxides (CO, CO2). We still have little under-
standing of how exposures to these different components contribute to
the development of chronic diseases (Forman and Finch, 2018).
It is well known that exposure to TRAP induces chronic respiratory
tract diseases (Zhang and Batterman, 2013). However, the UFP may
also enter the circulation, and reach and accumulate in distal organs (Li
et al., 2015), and even cross the blood-brain barrier (Oberdörster et al.,
2004). Consequently, epidemiological studies have shown that ex-
posure to TRAP is also associated with increased risk of cardiovascular
diseases (Downward et al., 2018), nervous system diseases (Calderón-
Garcidueñas and Villarreal-Ríos, 2017), and recently also diabetes
mellitus (Bowe et al., 2018).
In search for a better understanding of the pathomolecular me-
chanisms that link TRAP exposure to the increased risk of chronic
diseases, researchers have only recently started to investigate the role of
microRNAs (miRNAs). These small non-coding RNAs are involved in
posttranscriptional regulation by fine-tuning gene expression (Bartel,
2009). Consequently, miRNAs may impact on virtually all cellular
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processes and therefore, are to be regarded as key drivers in health and
disease. Through active secretion in the course of intercellular com-
munication, as well as through leakage upon tissue injury, miRNAs are
released into the peripheral circulation. This allows for non-invasively
interrogating organ pathogenesis and organ-specific mechanisms from
so called ‘liquid biopsies’ (Krauskopf et al., 2015).
A recent review describes miRNA changes as sensitive indicators of
the effects of acute and chronic environmental exposure (Vrijens et al.,
2015). The first evidence of air pollution-induced changes in miRNA
expression was provided through investigating the blood of healthy
steel plant workers before and after a week of occupational exposure to
metal-rich PM. Two miRNAs (miR-222 and miR-21) were identified to
be significantly increased in post-exposure samples (Bollati et al.,
2010).
Other studies have confirmed significant associations of PM ex-
posure and the cellular levels of miR-222, which has a function in cell
cycle and vascular biology, as well as miR-146a which plays an im-
portant role in inflammation, in adults (Fossati et al., 2014; Motta et al.,
2013). The first study reporting extracellular miRNAs in association to
air pollution identified miR-222 to positively correlate with UFP levels
in the saliva of school children (Vriens et al., 2016).
We were the first to study global plasma circulating miRNAs upon
moderate short-term ambient TRAP exposure in an intervention study
on a small population consisting of elderly subjects being either healthy
or suffering from COPD or ischemic heart disease. We showed that
signatures of extracellular miRNAs are responsive to TRAP exposure
which could be linked to multiple TRAP-induced health effects
(Krauskopf et al., 2018).
In the present study we build on this proof of concept and in-
vestigate plasma circulating miRNAs in healthy, non-smoking adults
exposed to varying levels of TRAP exposure within the ‘Transportation,
Air pollution and Physical Activities’ (TAPAS II) study.
2. Methods
2.1. Selection of the population
The TAPAS II cohort is (TAPAS II experimental study: respiratory
and inflammatory health effects of air pollution and physical activity) is
a controlled crossover study comprising of 30 participants (15 females
and 15 males) which executed four different scenarios. The four dif-
ferent scenarios were completed by each participant at random order
and included resting and intermittent physical activity (intervals of 15
minutes cycling and 15 minutes break for a total of 2 h) at low and high
TRAP (in a pedestrian square in la Barceloneta neighborhood and on a
bridge 5m above Ronda Litoral, the city's ring road, respectively) in the
city of Barcelona. Sessions were at least 5 days apart to allow sufficient
time to wash-out. To avoid the influence of weather the order of the
participants was fully randomized. Physical activity was modulated by
cycling at such a pace that the heart rate of the participants remained
within the range of 50–70% of their maximum rate. The inclusion cri-
teria for the subjects were healthy non-smokers, in the age range of
18–60, not taking any medication (except contraceptive pills) and not
suffering from any chronic disease. Also, participants were required not
to take herbal supplements or vitamins for the 7 previous days and not
having a chronic or acute disease i.e. infections, flu, etc.
The experiments took place within 4month between November
2013 and February 2014 from 8:00 to 10:00 AM. In the afternoon of the
day at 5.30 the subjects were transported to a nearby clinic for blood
sample collection. The blood samples were stored at −80 °C within 2 h
after collection.
For the present study we randomly selected 24 individuals from the
TAPAS cohort that completed all 4 scenarios (resting and cycling at
high and low exposure), thereby balancing for gender (Table 1). These
96 samples from the 24 participants were analyzed for global circu-
lating miRNA levels by next-generation technology. The study was
approved by the Ethic Review Committee of the Institut Municipal
d'Investigatió Mèdica, Barcelona and all participants gave written in-
formed consent.
2.2. External exposure assessment
Throughout the experiments, measurements comprised of analyzing
ambient air concentrations of PM10 and PM2.5 (DustTrack, DRX,Model
8534, TSI, Minnesota, USA), UFP (condensation particle counter, CPC,
Model 3007, TSI, Minnesota, USA), BC (portable aetholometer, Model
AE-51, McAgee Scientific, California, USA) and additionally nitrogen
oxide (NO), generic measurement for the nitrogen oxides (NOx=NO
+NO2) (nitric oxide monitor, Model 410 Nitric Oxide Monitor, 2B
Technologies, Colorado, USA, in combination with a nitrogen dioxide
converter, Model 401 NO2 Converter, 2B Technologies, Colorado,
USA), carbon monoxide (CO) and carbon dioxide (CO2) (Q-Track
(Model 7565, TSI, Minnesota, USA). Pearson correlation among ex-
posures was assessed using the ‘cor’ function of the R package ‘stats’.
The different personal exposure levels were compared between both
locations (low versus high exposure level) using a paired t-test (R
package ‘stats’, ‘t.test( )’ function). Per subject we calculated a Z-Score
as a representative of the external exposure level of each individual
pollutant Z-Score(compound) as well as the mixture of all pollutants Z-
Score(TRAP). The Z-Score(TRAP) was defined as the mean of the Z-Scores
for each compound: Z-Score(compound)= (X−μ)/σ (where X represents
the value of the subject, μ the mean and σ the standard deviation of the
population (Krauskopf et al., 2017). Therefore, Z-Score(TRAP)= 1/8 *
(Z-Score(NO)+ Z-Score(NOx)+ Z-Score(PM10)+ Z-Score(PM2.5)+ Z-
Score(BC)+ Z-Score(UFP)+ Z-Score(CO)+ Z-Score(CO2)).
2.3. Analytical procedures
Plasma samples were recovered from plasma separator tubes fol-
lowing centrifugation of whole blood at 1600g for 10min at 4 °C. To
avoid contamination of the plasma cmiRNAs with blood cell-derived
miRNAs, the plasma was subjected to a second centrifugation step at
16,000g before being stored at −80 °C (Kroh et al., 2010). Plasma
miRNAs were isolated using the miRNeasy Serum/Plasma kit (Qiagen)
and the quality was evaluated on a Bioanalyzer using the small RNA Kit
(Agilent). Samples were included in the analysis when showing a
minimum of 1 ng RNA yield and a peak around 21 nucleotides. The
sequencing libraries were prepared using the TruSeq Small RNA-Seq
Preparation Kit (Illumina), and sequenced by a HiSeq 2500 (Illumina)
according to the manufacture's protocol (GEO accession: GSE125647).
2.4. Statistical analysis
The quality of the sequencing data was assessed by FastQC and
subsequently processed using the miRge2 pipeline and miRBase (re-
lease 21) (Kozomara and Griffiths-Jones, 2014; Lu et al., 2018). Cir-
culating miRNAs were included in the analysis if they were detected in
at least 60% of the samples. The raw data were normalized and trans-
formed to log2 counts per million (logCPM) using the R package
‘DESeq2’ (Love et al., 2014). Technical confounders (miRNA isolation
batch effects, inter-day variations in library preparation and date of the




Range Mean Range Mean
Total 24 19,57 36 18.07,29.61 23.61
Males 12 20,57 35 22.11,28.47 24.43
Females 12 19,55 38 18.07,29.61 22.78
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(LMM) using the R package ‘lme4. After de-noising the data we used a
multivariate normal model (MVN) to find associations between the Z-
Score(TRAP) and the circulating miRNA levels, and between the in-
dividual air pollutants and the circulating miRNA levels using the R
package ‘nlme’. All models were adjusted for the confounders gender,
age, BMI, physical activity and a variable indicating the order in which
the four different scenarios were implemented. The IDs of the subjects
were used as a grouping factor. Resulting p-values were declared sig-
nificant based on a false discovery rate less than or equal to 0.1.
To test the stability of the model we performed leave-one-out cross
validation (LOOCV). Briefly: one subject was left out at a time; MVN
was performed on the remaining n−1 subjects; until each subject was
left out exactly once. At the end, we compared all resulting n coefficient
vectors with the coefficient vector of the full dataset set including all
subjects.
We also tested the influence of physical activity on the circulating
miRNAs by applying a negative binominal test using the R package
‘DESeq2’, thereby adjusting for the exposure Z-Score(TRAP), gender, age
and BMI. We declared the association of physical activity significant
based on a false discovery rate less than or equal to 0.1 and a log2 fold
change> 1.
2.5. miRNA-gene-disease network
To identify the biological mechanisms in which the TRAP-associated
miRNAs are involved we performed an integrated network analysis.
First, potential gene targets for all significantly TRAP-associated
miRNAs were derived from the experimentally validated miRNA-target
interaction database miRTarBase (Chou et al., 2018). Only strong
miRNA-gene interactions that have been validated by reporter assay,
western blot or qPCR were considered. Next, the DisGeNET database
(v5.0) was used to find genes associated with TRAP exposure-related
diseases (Piñero et al., 2017). We manually selected cardiovascular
diseases (“Cardiovascular Diseases”, “Myocardial Ischemia”, “Heart
failure”, “Inflammation”, “Cardiac Arrhythmia”, “Ischemia”, “Heart
Diseases”, “Coronary heart disease”, and “hypertensive disease”), re-
spiratory tract diseases (“Chronic Obstructive Airway Disease”, “Non-
Small Cell Lung Carcinoma”, “Small cell carcinoma of lung” and
“Asthma”), nervous system diseases (“Parkinson's disease”, “Dementia”
and “Alzheimer's Disease”) and Diabetes (“Diabetes Mellitus”). Only
expert-curated associations were considered. Integration, network
analysis and visualization was performed using cytoscape (v2.7)
(Shannon et al., 2003).
3. Results
3.1. Exposure
Ambient concentrations of 8 pollutants for the low and high ex-
posure sites (Barceloneta and Ronda respectively) are shown in Table 2.
A paired t-test showed that for all pollutants the exposure was sig-
nificantly higher in the high pollution site when compared to the low
pollution site (Table 2). The eight exposures showed Pearson correla-
tion coefficients (r) between 0.11 and 0.99 with CO2 being the least
correlated with the remaining exposures (r < 0.51) and BC and CO2
(r= 0.90), PM2.5 and PM10 (r= 0.92), and NOx, NO and UFP
(r > 0.96) showing strong correlations. The Z-Score(TRAP) showed high
correlations with NO, NOx, PM2.5, BC, UFP and CO2 (r between 0.92
and 0.96) and moderate correlations between PM10 (r= 0.74) and CO
(r= 0.51) (Fig. 1).
3.2. Small RNA-sequencing
The sequencing of the 96 samples from the 24 subjects resulted on
average 6.6*106 (SD ± 4.5*106) sequencing reads. Due to low se-
quencing coverage three samples were excluded from further analysis.
In total we detected 83 miRNAs with sufficient coverage across the
remaining samples. The most abundant plasma miRNAs were miR-486-
5p (13 logCPM), miR-92a-3p (10.80 logCPM), miR-423-5p (8.38
logCPM), miR-16-5p (8.34 logCPM) and miR-22-3p (8.05 logCPM). The
mean expression of the detected miRNAs was 4.32 (± 2.01) logCPM
across all plasma samples.
3.3. TRAP-associated miRNAs
We applied a MVN model in combination with the LMM to associate
the detected plasma circulating miRNAs to the difference in exposure
(Z-Score(TRAP)) between Barceloneta and Ronda. The analysis showed
that 9 circulating miRNAs were significantly associated with exposure.
The miRNAs miR-28-3p, miR-222-3p, miR-146-5p, miR-30b-5p/30c-5p
and miR-320a-3p/320b/320c/320d/320e showed a positive associa-
tion with the Z-Score(TRAP) intensity, and miR-532-5p, miR-192-5p/
215-5p, miR-144-3p and miR-425-5p showed a negative association
with the Z-Score(TRAP) intensity (Fig. 2). The observed association
coefficients remained subtle (range: −0.13, 0.13) even if they appeared
significant after FDR correction. Consequently, we performed a LOOCV
by removing each subject from the data and performed the same model
on this test dataset. After these iterations we compared the coefficients
to the ones from the full dataset. The analysis showed that the beta
Table 2
TRAP data at high and low exposure sites (Barceloneta vs Ronda) and results
from paired t-tests. Significant differences in exposure between high and low
exposure sites for all pollutants.
Pollutant Barceloneta Ronda Paired t-
test
Mean ±SD Mean ± SD P-value
NO (ppb) 78.27 52.93 588.70 194.00 2.20E-16
NOx (ppb) 102.84 61.56 679.39 204.76 2.20E-16
PM10 (μg/m3) 64.77 41.72 122.87 42.48 2.20E-16
PM2.5 (μg/m3) 38.75 13.40 82.71 18.01 1.15E-09
BC (μg/m3) 6127.87 4363.18 23,408.64 5421.31 2.20E-16
UFP (particles/
cm3)
45,712.13 20,488.19 245,446.17 71,906.60 2.20E-16
CO (ppm) 0.99 1.75 2.69 4.38 1.48E-02
CO2 (ppm) 420.36 38.45 499.11 32.51 2.20E-16
Fig. 1. Pearson correlation among the eight air contaminants. The analysis
revealed that the exposures showed strong positive correlations between BC
and CO2 (r= 0.90), PM2.5 and PM10 (r= 0.92), and NOx, NO and UFP
(r > 0.96) and a less strong positive correlation CO2 with the remaining ex-
posure (r < 0.51).
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coefficients were robust and not depending on one or a few observa-
tions (Fig. 3).
3.4. Individual exposure-associated miRNAs
Next, we applied the same MVN model assess the association be-
tween each individual pollutant and miRNAs. We identified 29 miRNAs
to be significantly associated with individual TRAP exposures across all
Fig. 2. Boxplot of observed significant exposure associated circulating miRNA levels (Log2) for all individuals. The figure demonstrates that expression levels of miR-
28-3p, miR-222-3p, miR-146-5p, miR-30b-5p/30c-5p and miR-320a-3p/320b/320c/320d/320e was higher in Ronda compared with Barceloneta which implies a
positive association with the Z-Score(TRAP) intensity, and for miR-532-5p, miR-192-5p/215-5p, miR-144-3p and miR-425-5p a negative association with the Z-
Score(TRAP) intensity was found.
Fig. 3. Boxplot of the observed coefficients (Beta) from the cross validation step. Boxplots show the coefficients across the 24 validation steps of the LOOCV (see
methods). The red dot indicates the coefficient of the model using the complete dataset. The figure shows that the subtle coefficients are robust across all miRNAs
associated with the Z-Score(TRAP) and not a result of a single or a few observations. (For interpretation of the references to colour in this figure legend, the reader is
referred to the web version of this article.)
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subjects. These miRNAs showed in total 61 significant associations with
6 individual pollutants, namely 8 associations with BC, 16 associations
with CO, 13 associations with CO2, 10 associations with NO, 9 asso-
ciations with NOx and 5 associations with UFP (Fig. 4). We did not find
any significant associations with PM10 and PM 2.5. Also here we per-
formed a LOOCV and received robust coefficients (Fig. 5).
We also analyzed the data without adjustment for confounders but
while correcting for technical variation. While we identified 9 miRNAs
Fig. 4. Significant associations of the individual TRAP pollutants and circulating miRNAs. The figure shows the significant TRAP associated circulating miRNAs based
on a false discovery rate of less than or equal to 0.1. Green indicates a significant negative correlation, and red a significant positive correlation with the individual
pollutants. Grey indicates that no significant association was observed. (For interpretation of the references to colour in this figure legend, the reader is referred to the
web version of this article.)
Fig. 5. Boxplot of the observed coefficients (Beta) from the cross validation step. Boxplots show the coefficient across all models of the validation step. The red dot
indicates the coefficient of the model using the complete dataset. The figure shows that the subtle coefficients are robust across all miRNAs associated with the
individual pollutants, and not a result of a single or a few observations. (For interpretation of the references to colour in this figure legend, the reader is referred to the
web version of this article.)
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significantly associated with the combined Z-Score when adjusting for
physiological confounders and technical variation, 8 of these miRNAs
remained significant when only adjusting for the technical variation.
The analysis regarding the individual pollutants identified 29 sig-
nificant miRNA associations when adjusting for physiological con-
founders and technical variation. While only adjusting for technical
variation 24 of these miRNAs remained significant.
3.5. TRAP-associated miRNA-gene-disease network
To identify potentially perturbed pathways related to the TRAP-
associated miRNAs we created a miRNA target disease interaction
network. For this analysis we included the 29 miRNAs that were as-
sociated with the individual TRAP pollutants. The miRNA target in-
teraction database ‘mirTarBase’ identified 616 strong gene targets for
all TRAP-associated miRNAs. The identified targets were then used to
explore the gene-disease interaction database ‘DisGeNET’ for poten-
tially perturbed disease interactions for each miRNA. Integration of the
miRNA-gene target and the gene-disease interactions networks resulted
in a miRNA-disease interaction network consisting of 936 interactions
for 27 miRNAs, 136 genes and 15 TRAP associated diseases. Only miR-
941 and miR-423-3p did not return any interaction. Subsequently, cy-
toscape (v2.7) was used for network analysis and network visualization.
For visualization purposes only gene targets were included that were
targeted by at least 3 miRNAs (Fig. 6). This analysis revealed four hub
genes that appeared to dominate the network. TP53 is potentially tar-
geted by 8 miRNAs (hsa-miR-10b-5p, hsa-miR-150-5p, hsa-miR-151a-
5p/151ba-5p, hsa-miR-222-3p, hsa-miR-27a-3p/27b-3p, hsa-miR-28-
3p, hsa-miR-30b-5p/30c-5p-5p and hsa-miR-30d-5p) and implicated in
the development of 3 diseases (Lung Cancer, Ischemia and COPD). Four
miRNAs (hsa-miR-103a-3p/107, hsa-miR-150-5p, hsa-miR-181a-5p and
hsa-miR-378a/c/d/e-3p) potentially target VEGFA, which is implicated
in the pathogenesis of 7 diseases (Alzheimer's disease, Lung Cancer,
Asthma, Inflammation, Myocardial Ischemia, Heart failure and Heart
Diseases). IL6 is potentially targeted by 4 miRNAs (hsa-let-7a-5p/7c-5p,
hsa-let-7f-5p, hsa-miR-103a-3p/107 and hsa-miR-146a-5p) and im-
plicated in 5 diseases (Inflammation, Parkinson's disease, Myocardial
Ischemia, Heart failure and Ischemia). PTEN is targeted by 8 miRNAs
(hsa-miR-103a-3p/107, hsa-miR-10b-5p, hsa-miR-130a-3p, hsa-miR-
142-5p, hsa-miR-144-3p, hsa-miR-181a-5p, hsa-miR-222-3p and hsa-
miR-425-5p) and implicated in 3 diseases (Lung Cancer, Asthma and
Cardiovascular Diseases).
3.6. Circulating miRNAs and physical activity
Since it is known that circulating miRNAs participate in the phy-
siological response we speculated that physical activity might confound
the effect of TRAP exposure on the circulating miRNAs. Therefore we
tested if the identified miRNAs are responsive to physical activity, and
found 2 miRNAs to be upregulated (hsa-miR-146b-5p and hsa-miR-19b-
3p) and 6 miRNAs are downregulated (hsa-miR-99b-5p, hsa-miR-125a-
5p, hsa-miR-484, hsa-miR-151a-5p/151b, hsa-let-7b-5p and hsa-miR-
4433b-5p) upon physical activity. Of these only hsa-miR-151a-5p/151b
and hsa-miR-484 has been identified to be associated with the ex-
posure.
4. Discussion
We performed a global analysis of circulating miRNA in plasma of
subjects exposed to different levels of ambient TRAP. The cross-over
study design with sampling taking place after resting and physical ac-
tivity cycles in two different exposure scenarios, combined with per-
sonal air pollution exposure measurements allowed us to identify 29
miRNAs that are perturbed in correlation to the TRAP exposure. Of
these, 9 miRNAs were associated with the mixture of TRAP (Z-
Score(TRAP)) and 29 miRNAs were associated with 6 individual
compounds of TRAP: NO, NO2, CO, CO2, BC and UFP. We did not find
significant associations between PM10 or PM2.5 and circulating miRNAs.
We validated the response of 2 miRNAs, namely hsa-miR-222 and
hsa-miR-146a, that have been extensively studied in humans upon long-
term exposure to PM (Fossati et al., 2014; Motta et al., 2013; Vriens
et al., 2016). Both have been positively correlated with the mixture of
TRAP and the individual compounds UFP, NO, NO2 and CO in the
present study. Furthermore, we identified multiple miRNAs responding
to higher TRAP levels that have not been identified earlier (Fig. 4).
Interestingly, multiple of these miRNAs have already been investigated
in relation to diseases that are induced by TRAP exposure. For instance
the roles of hsa-miR-103a-3p/107, hsa-miR-146a and hsa-miR-181 in
Alzheimer's diseases, and their potential as therapeutic targets and di-
agnostic biomarkers has been recently reviewed (Gupta et al., 2017).
The miRNAs hsa-miR-222, hsa-miR-146a, hsa-miR-27a-3p/27b-3p and
hsa-miR-320 have been confirmed in patients suffering from cardio-
vascular disease, vascular inflammation, cardiomyocyte apoptosis and
cardiac hypertrophy (de Lucia et al., 2017; Ding et al., 2017). Fur-
thermore, hsa-let-7, hsa-miR-130a-3p, hsa-miR-222-3p, hsa-miR-30b-
5p/30c-5p, hsa-miR-150-5p have been found in patients with multiple
respiratory diseases (Brown et al., 2014).
Results of an integrated network analysis highlighted the putative
role of these miRNAs in respiratory, cardiovascular and neurodegen-
erative diseases as well as diabetes mellitus. This network suggests
through which miRNA-gene interactions the TRAP-responsive miRNAs
may act as drivers of disease. The hub genes TP53, VEGFA, IL6 and
PTEN were identified, which are involved in the pathogenesis of all
major TRAP-induced diseases (Fig. 6).
We found 3 miRNAs overlapping with an earlier study (Krauskopf
et al., 2018) we performed on TRAP-associated circulating miRNAs
(hsa-miR-103a-3p/107, hsa-miR-150-5p, hsa-miR-30d-5p). However, in
that study hsa-miR-103a-3p/107 showed a positive, and hsa-miR-150-a
and hsa-miR-30d-5p a negative association with PM10 and BC, while in
the present study we identified hsa-miR-103a-3p/107 and hsa-miR-
150-5p were positively and hsa-miR-30d-5p negatively associated with
the carbon oxides. This incoherence in findings may be due to the fact
that in the present study not only the exposure intensities were dras-
tically higher but the pollution has also originated from different
sources (diesel power versus general urban pollution). Furthermore, the
study designs (physical activity vs resting) and population (disease
endpoints) and blood handling were different. Further, as a con-
sequence of lower sequencing depth in the present study we did not
detect the cardiovascular disease-associated miRNAs has-miR-499 and
has-miR-133 that have been identified as TRAP-responsive in our pre-
vious study (Krauskopf et al., 2018). This limited overlap in results
between the two cohorts was reported in earlier studies on tran-
scriptomics and miRNA analysis in peripheral blood cells (Espín-Pérez
et al., 2018).
It has previously been reported that miRNAs are responsive to
physical activity (Xu et al., 2015). Since these miRNAs could potentially
confound the results of this study we performed a test to identify these
miRNAs. Only 2 miRNAs were altered upon physical activity, which
were also declared significantly associated with the exposure. While
hsa-miR-484 is negatively associated with exposure and physical ac-
tivity, hsa-miR-151a-5p/151b is downregulated upon physical activity
but positively associated with TRAP exposure.
5. Conclusions
The study identified a compound-specific circulating miRNA profile
associated with short-term exposure to ambient TRAP exposure. We
confirmed TRAP-induced perturbations of previously identified
miRNAs, but also discovered multiple novel potentially TRAP-re-
sponsive miRNAs. Integrated network analysis showed that these
miRNAs possibly contribute to the chain of events connecting TRAP
exposure to increased risk of respiratory, cardiovascular as well as
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neurodegenerative diseases and diabetes mellitus. Despite the small
sample size, and the necessity of studies with a more dedicated design
to the individual miRNAs identified in this study the proposed circu-
lating miRNAs may present promising biomarker candidates to be used
in health risk assessment in relation to short-term TRAP exposure and
TRAP-induced health effects.
Fig. 6. miRNA-gene-disease network. The network shows the TRAP-associated miRNAs, gene targets and expert curated disease interactions. Only gene targets are
included that had a minimum of 3 incoming interactions with miRNAs. The edges between miRNAs and genes are strong validated interactions from ‘miRtarBase’.
The edges between gene targets and disease outcomes are indicating expert curated associations derived from ‘DisGenet’. The amount of edges corresponds to the
number of evidence found in either ‘miRtarBase’ or ‘DisGenet’. Node size corresponds to the number of interactions.
J. Krauskopf, et al. Environment International 128 (2019) 193–200
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